New Drug Approval ( 28 Sept 2018 - 30 October 2018)

By :

New Ebola Vaccine for Exposure Risk

Hyrimoz (adalimumab-adaz) Injection Date of Approval: October 30, 2018 Treatment for: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease -- Maintenance, Ulcerative Colitis, Plaque Psoriasis Bijuva (estradiol and progesterone) Capsules Date of Approval: October 28, 2018 Treatment for: Menopausal Vasomotor Symptoms Xofluza (baloxavir marboxil) Tablets Date of Approval: October 24, 2018 Treatment for: Influenza Khapzory (levoleucovorin) for Injection Date of Approval: October 19, 2018 Treatment for: Methotrexate Rescue, Folic Acid Antagonist Overdose, Colorectal Cancer Talzenna (talazoparib) Capsules Date of Approval: October 16, 2018 Treatment for: Breast Cancer Yutiq (fluocinolone acetonide) Intravitreal Implant Date of Approval: October 12, 2018 Treatment for: Non-Infectious Posterior Segment Uveitis Tegsedi (inotersen) Injection Date of Approval: October 5, 2018 Treatment for: Amyloidogenic Transthyretin Amyloidosis Revcovi (elapegademase-lvlr) Injection Date of Approval: October 5, 2018 Treatment for: Adenosine Deaminase Severe Combined Immune Deficiency (ADA-SCID) Nuzyra (omadacycline) for Injection and Tablets Date of Approval: October 2, 2018 Treatment for: Skin and Structure Infection, Pneumonia Seysara (sarecycline) Tablets Date of Approval: October 1, 2018 Treatment for: Acne Xyosted (testosterone enanthate) Subcutaneous Injection Date of Approval: September 28, 2018 Treatment for: Hypogonadism -- Male #drug #Approval #fda #FDA
Rate UsDon’t love itNot greatGoodGreatLove itRate Us
Your opinion
arrow&v
arrow&v

PHAF DIC Team

Approval of new treatment for adults with partial-onset seizures

PHAF Team

Navigating the New Clozapine REMS

PHAF Team

LENVIMA (lenvatinib) capsules

PHAF Team

FDA approval : first treatment for frequent urination at night

PHAF Team

A new eczema drug Dupixent : FDA Approval

PHAF Team

New drug that can prevent breast cancer growth identified

© 2019 PHAF  || All rights reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.